Emma J. Groen

Targeted Therapy in Advanced Melanoma With Rare <i>BRAF</i> Mutations

Christian Menzer, Alexander M. Menzies, Matteo S. Carlino et al. · Journal of Clinical Oncology · 2019 · 124 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy

Vincent M. T. de Jong, Yuwei Wang, Natalie D. ter Hoeve et al. · Zurich Open Repository and Archive (University of Zurich) · 2022 · 103 citations · Full text

Medicine, Immunology, Oncology +11

Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol

Ariane A. van Loevezijn, Marieke E. M. van der Noordaa, Marcel P. M. Stokkel et al. · Breast Cancer Research and Treatment · 2022 · 75 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Grading of Neuroendocrine Neoplasms: Mitoses and Ki-67 Are Both Essential

Marie‐Louise F. van Velthuysen, Emma J. Groen, Vincent van der Noort et al. · Neuroendocrinology · 2014 · 66 citations

Medicine, Oncology, Pathology +17

Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma <i>In Situ</i> —A Nested Case–Control Study

Lindy L. Visser, Lotte E. Elshof, Michael Schaapveld et al. · Clinical Cancer Research · 2018 · 44 citations · Full text

Medicine, Oncology, Surgery +16